Global Head of Finance
Kevin joined Caligor Coghlan Pharma Services as Global Head of Finance July 2020. He is responsible for leading Caligor Coghlan Pharma Services’ global Finance team.
Global Head and Vice President, Quality, Regulatory, and Strategic Services
Geoff joined Caligor Coghlan Pharma Services as Global Vice President of Quality, Regulatory, and Strategic Services in June 2019. He is responsible for leading Caligor Coghlan Pharma Services’ global Quality, Regulatory, and consulting teams.
Geoff is a highly experienced, results-oriented global regulatory professional, with very strong strategic capabilities and a very solid technical background that has allowed him to lead companies and projects to new levels of success in a variety of highly competitive industries, cutting-edge markets, and fast-paced environments.
Geoff brings 20+ years of expertise and a demonstrated record of regulatory and business accomplishments covering the United States, Europe, Asia Pacific (with in depth experience in Japan, China, and Korea), and Middle East having lived and worked in many countries championing regulatory affairs.
His proven abilities in the successful creation and implementation of global regulatory strategies from concept to commercialization, business planning, global growth strategies, in-licensing and commercial valuations has helped numerous companies reach their business objectives on a global scale.
He has been directly involved in all phases of product development globally. His specialties include global and product regulatory strategy development; market assessments; agency interactions; HEOR and Regulatory Economics; extensive global experience in drug and device development; clinical trials, and approvals, including such areas as: biosimilar development and approval; nanotechnology, stem cell and gene therapy products, medical devices; in-licensing and divestitures; and regulatory due diligence.
Geoff is a frequent lecturer on international regulatory affairs and regulatory law, as well as a contributing member to several organizations including TOPRA and lecturer at Cranfield for the Regulatory Affairs education programs.
Global Head and Vice President, Commercial and Clinical Supply Services
Kerry joined Caligor Coghlan Pharma Services as Global Vice President of Commercial in August 2018. In December 2019, she was appointed Global Head and Vice President of Commercial and Clinical Supply Services where she is responsible for leading Caligor Coghlan Pharma Services’ Clinical Supply Services division as well as global sales and marketing.
Kerry has more than fifteen years of success designing, launching, marketing, and selling solutions in the healthcare industry. Prior to joining Caligor Coghlan Pharma Services, Kerry spent seven years at Quest Diagnostics, a market leader in diagnostic services. There she served as the Business Leader for Quest Diagnostics’ Payer Analytics Portfolio, where she was responsible for developing the product pipeline, building the go-to-market strategy, and leading marketing and commercialization efforts. Kerry began her career in sales and marketing with Pfizer and held roles of increasing responsibility at various pharmaceutical and healthcare equipment companies.
Kerry holds a bachelor’s degree in statistics and certification in actuarial science from Florida State University.
Senior Director, Global Operations
CCPS Responsible Person
Phil joined Caligor Coghlan Pharma Services in 2012 to lead UK Operations, and he was promoted to Senior Director of Global Operations in 2019. In his current role, Phil is responsible for leading Caligor Coghlan Pharma Services’ global operations and overseas both its US and UK facilities. He also serves as its Responsible Person.
Phil has more than 30 years of experience in operations and supply chain management in the pharmaceutical industry. Prior to joining Caligor Coghlan Pharma Services, Phil spent 7 years at Pharmarama working in wholesale distribution of comparators and unlicensed medicines. Prior to that, Phil spent 17 years at GlaxoSmithKline where he gained experience in veterinary & human medical vaccine manufacturing, radiopharmaceutical analysis of clinical samples, sterile manufacturing of liquid filled medicines, packaging & labeling of commercial medicines, and pharmaceutical supply chain management. In addition, Phil spent 2 years at Pfizer in clinical supply chain coordination.
Phil holds an HNC in Industrial Microbiology and has a first class honours degree in Pharmaceutical Sciences from Greenwich University.
Senior Global Director, Information Technology
Margo joined Caligor Coghlan Pharma Services as Senior Global Director of Information Technology in January 2021. She is responsible for the strategic direction, vision and performance of Caligor Coghlan Pharma Services’ technology portfolio.
Margo began her career in Information Technology with the US Air Force, and she has held positions of increasing responsibility at various companies over the last 25 years. Prior to joining Caligor Coghlan Pharma Services, Margo spent almost 10 years at IQVIA, a full-service Clinical Research Organization, where she served as an IT Director responsible for various projects and programs.
Margo holds a bachelor’s degree in Management Information Systems and a master’s degree in Leadership and Organizational Effectiveness.
Terry founded The Coghlan Group, Inc. and served as its Chairman, President and Chief Executive Officer, from 1996 until 2017. He now serves as a Board Member and consultant for Caligor Coghlan Pharma Services.
CLINICAL SUPPLY SERVICES
Clinical Trial Material Sourcing
Packaging and Labeling
Global Storage & Distribution
Clinical Returns and Destruction
EARLY ACCESS TO MEDICINES SERVICES
Our support and oversight of Early Access to Medicines programs enables patients to receive life-improving medications faster.
about CALIGOR COGHLAN
At CCPS, we apply our expertise to ensure your success. Our goal is simple: to help you provide patients with faster access to relief. We create strategic solutions to help you bring your pharmaceutical, biotechnology, or medical device asset to market in an efficient and cost-effective manner, demonstrating consistent dedication to quality assurance and regulatory compliance along every step of the way.